arsenic has been researched along with Carcinoma, Lewis Lung in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Camphausen, K; Chinen, L; Dilda, PJ; Don, AS; Dyszlewski, M; Hemenway, C; Hogg, PJ; Karwa, A; Kuan, KT; MacDonald, J; Massamiri, T; Naik, A; Park, D; Warner, B; Wong, JW | 1 |
Calderon, PB; Dauguet, N; Diepart, C; Feron, O; Gallez, B; Grégoire, V; Jordan, BF; Karroum, O; Leveque, P; Magat, J; Stockis, J; Verrax, J | 1 |
2 other study(ies) available for arsenic and Carcinoma, Lewis Lung
Article | Year |
---|---|
Noninvasive imaging of cell death using an Hsp90 ligand.
Topics: Animals; Arsenicals; Carbocyanines; Carcinoma, Lewis Lung; Cell Death; Colorectal Neoplasms; HSP90 Heat-Shock Proteins; Humans; Jurkat Cells; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasms; Pentetic Acid; Peptides; Protein Binding; Radioisotopes | 2011 |
Arsenic trioxide treatment decreases the oxygen consumption rate of tumor cells and radiosensitizes solid tumors.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Lewis Lung; Combined Modality Therapy; Disease Models, Animal; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C57BL; Oxides; Oxygen Consumption; Radiation-Sensitizing Agents | 2012 |